Table 2.
Correlations between dTSR and vTSR and corresponding clinicopathologic characteristics.
| Test set for TSR assessment (n = 358) | P-value | ||
|---|---|---|---|
| dTSR-low | dTSR-high | ||
| (n = 121) | (n = 237) | ||
| Age | 0.0006 | ||
| < 60 | 28 (23.14%) | 100 (42.19%) | |
| ≥ 60 | 93 (76.86%) | 137 (57.81%) | |
| Sex | 0.0121 | ||
| Male | 89 (73.55%) | 141 (59.49%) | |
| Female | 32 (26.45%) | 96 (40.51%) | |
| Lauren type | < 0.0001 | ||
| Intestinal | 47 (38.84%) | 29 (12.24%) | |
| Diffuse | 61 (50.41%) | 194 (81.85%) | |
| Indeterminate | 13 (10.75%) | 29 (5.91%) | |
| Pathology | < 0.0001 | ||
| Hepatoid adenocarcinoma | 1 (0.83%) | 0 (0.00%) | |
| Mucinous adenocarcinoma | 13 (10.74%) | 14 (5.91%) | |
| Signet-ring cell carcinoma | 8 (6.61%) | 28 (11.81%) | |
| Tubular adenocarcinoma, well/moderately differentiated | 46 (38.02%) | 30 (12.66%) | |
| Tubular adenocarcinoma, poorly differentiated | 53 (43.80%) | 165 (69.62%) | |
| AJCC stage | 0.0195 | ||
| Stage III | 66 (54.55%) | 97 (40.93%) | |
| Stage IV | 55 (45.45%) | 140 (59.07%) | |
| vTSR | < 0.0001 | ||
| Kappa = 0.623 | |||
| vTSR-low | 98 (80.99%) | 30 (12.66%) | |
| vTSR-high | 23 (19.01%) | 207 (87.34%) | |